News
One great example of a “what the hell is happening here” story run just the other day that opened with, “Orange juice, known ...
One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
17h
Medpage Today on MSNCDC Funds Frozen; Prasad Didn't Reject Replimune; Filling the Gender Care GapThe amount of frozen funds could be as high as $200 million, or potentially more than $300 million, according to two ...
Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...
18hOpinion
The New Republic on MSNPete Hegseth Unveils Return of Pro-Slavery MonumentU.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be reinstalled in Arlington Cemetery ...
20hOpinion
The New Republic on MSNIs Trump About to Drag Joe Rogan Into the Epstein Files Debacle?The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...
Laura Loomer, a far-right activist once banned from social media, has become an influential, unofficial advisor to Donald ...
Dr Vinay Prasad was asked to step down as the FDA's top vaccine official following several controversies during his brief tenure.
New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results